Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2013Clinical Cancer Research

PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

FDFiona DayCalvary Mater Newcastle HospitalRJRobert N. JorissenFlinders UniversityLLLara LiptonAustin Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Day et al. (2013) studied this question.

synapsesocial.com/papers/6a081da9280cd4e998e8a7bbhttps://doi.org/10.1158/1078-0432.ccr-12-3614
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance2008 · 274 citations
  2. 2Comprehensive molecular characterization of human colon and rectal cancer2012 · 8,844 citations
  3. 3Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer2009 · 257 citations
  4. 4PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations2008 · 238 citations